FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084896 [Registered on: 16/04/2025] Trial Registered Prospectively
Last Modified On: 12/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Single Arm Study 
Public Title of Study   Early screening of Acute Stress after ICU discharge using PCL5 questionnaire 
Scientific Title of Study   Assessment of incidence of acute stress disorder and Post-traumatic stress disorder among ICU survivors using Post traumatic stress disorder checklist for DSM (PCL-5) 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR G Swetha 
Designation  Academic registrar, Drnb critical care medicine 
Affiliation  Apollo Main hospital, Chennai 
Address  A3 first floor Valliammai apt bheema sena garden street mylapore chennai

Chennai
TAMIL NADU
600004
India 
Phone  7598554342  
Fax    
Email  swethasuba2711@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR N RAMAKRISHNAN 
Designation  Head & Senior Consultant, Department of Critical Care and Sleep Medicine Apollo Hospitals,Chennai. 
Affiliation  Apollo Main hospital, Chennai 
Address  A3 first floor Valliammai apt bheema sena garden street
mylapore
Chennai
TAMIL NADU
600004
India 
Phone  984085515  
Fax    
Email  icudoctor@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR N RAMAKRISHNAN 
Designation  Head & Senior Consultant, Department of Critical Care and Sleep Medicine Apollo Hospitals,Chennai. 
Affiliation  Apollo Main hospital, Chennai 
Address  A3 first floor Valliammai apt bheema sena garden street
mylapore
Chennai
TAMIL NADU
600004
India 
Phone  984085515  
Fax    
Email  icudoctor@gmail.com  
 
Source of Monetary or Material Support  
APOLLO HOSPITALS, GREAMS ROAD, 21 GREAMS LANE, CHENNAI 600006 
 
Primary Sponsor  
Name  Apollo hospitals 
Address  Apollo hospitals,GREAMS ROAD,21 GREAMS lane,Chennai 600006 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr swetha  Apollo main hospital chennai  MULTIDISCIPLINARY CRITICAL CARE UNIT, wards in main block and sindoori block, Apollo hospital,GREAMS road, 21 GREAMS lane, Thousand lights, chennai 600006
Chennai
TAMIL NADU 
07598554342

swethasuba2711@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethucs committee, apollo hospitals  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F430||Acute stress reaction,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  Adult patients more than 18 years
Patients admitted for more than 48 hours in intensive care unit and discharged from CCU(to ward, hdu, home)
 
 
ExclusionCriteria 
Details  Patients with Past history of psychiatric illness
Patients unable to give consent
Multiple admissions to ICU within the same hospital admission
Patients not able to fully understand and complete the questionnaire 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To study the incidence of acute stress disorder among ICU survivors using PCL-5 questionnaire
 
PCL 5 Questionnaire Administered AT 1-8 days 4-6 weeks and 8-12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To study the incidence of PTSD among ICU survivors using PCL-5 questionnaire
To study the factors associated with incidence of acute stress disorder & PTSD among ICU survivors
 
PCL5 questionnaire administered at 1-8 days, 4-6 weeks & 8-12 weeks 
 
Target Sample Size   Total Sample Size="175"
Sample Size from India="175" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   patient admitted in ICU will be followed up at 1-8 days, 4-6 weeks and 8-12 weeks. age,gender,APACHE 4 score charlson comorbidity index, vasopressor use, benzodiazepine use, opioid use,mechanical ventiation, ICU length of stay - DATA collected. PTSD score assesed using PCL5 questionnaire. if score more than 33 - patient sent for psychiatric counselling 
Close